Estimating rates of true high-grade disease in the Prostate Cancer Prevention Trial

Cancer Prevention Research

Volumn 1, Issue 3, 2008, Pages 182-186

  Pinsky, Paul ^a   Parnes, Howard ^a   Ford, Leslie ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FINASTERIDE; PLACEBO;

AGED; ARTICLE; BIOPSY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; HUMAN; LABORATORY DIAGNOSIS; MALE; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTINEOPLASTIC AGENTS; BIOPSY; DISEASE PROGRESSION; FALSE POSITIVE REACTIONS; FINASTERIDE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PLACEBOS; PROSTATIC NEOPLASMS;

EID: 56349096425     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-07-0007     Document Type: Article

References (6)

1. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. New Engl J Med 2003;349: 215-24.
2. King CR, Long JP. Prostate biopsy grading errors: a sampling problem? Int J Cancer 2004;90:326-30.
3. Kulkarni GS, Al-Azab R, Lockwood G, et al. Evidence for a biopsy derived grade artifact among larger prostate glands. J Urol 2006;175:505-9.
4. Lucia SM, Epstein JI, Goodman PJ, et al. Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2007; 99:1375-83.
5. Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods 2002;7: 147-77.
6. Cohen YC, Liu KS, Heyden NL, et al. Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2007;99:1366-74.